Gait patterns of patients with inclusion body myositis

被引:13
作者
Bernhardt, K. A. [1 ]
Oh, T. H. [2 ]
Kaufman, K. R. [1 ]
机构
[1] Mayo Clin, Mot Anal Lab, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA
关键词
Inclusion body myositis; Knee kinematics; Knee kinetics; Quadriceps weakness; MUSCLE WEAKNESS; NORMAL WALKING; FEATURES; DISEASE;
D O I
10.1016/j.gaitpost.2010.12.021
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Inclusion body myositis (IBM) is a progressive, inflammatory muscle disease that is known to cause quadriceps weakness and knee buckling during gait. This is the first known report of gait characteristics in patients with IBM. Nine subjects with IBM and quadriceps weakness underwent gait analysis and quantitative strength testing. A wide range of strength and gait abilities were present in the subject group. Subjects with stronger knee extensors exhibited nearly normal sagittal knee kinematics and kinetics. As quadriceps strength decreased, kinematic and kinetic patterns were increasingly abnormal. Exceptions to this pattern could be explained by examining strength at adjacent joints. Gait analysis and strength testing is a helpful tool in evaluating the functional status of this population and aiding in determination of the needs for interventions such as assistive devices. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:442 / 446
页数:5
相关论文
共 23 条
[1]  
Andres PL, 1989, QUANTIFICATION NEURO, P87
[2]   Epidemiology of inclusion body myositis in the Netherlands:: A nationwide study [J].
Badrising, UA ;
Maat-Schieman, M ;
van Duinen, SG ;
Breedveld, F ;
van Doorn, P ;
van Engelen, B ;
van den Hoogen, F ;
Hoogendijk, J ;
Höweler, C ;
de Jager, A ;
Jennekens, F ;
Koehler, P ;
van der Leeuw, H ;
de Visser, M ;
Verschuuren, JJ ;
Wintzen, AR .
NEUROLOGY, 2000, 55 (09) :1385-1387
[3]   Inclusion body myositis - Clinical features and clinical course of the disease in 64 patients [J].
Badrising, UA ;
Maat-Schieman, MLC ;
van Houwelingen, JC ;
van Doorn, PA ;
van Duinen, SG ;
van Engelen, BGM ;
Faber, CG ;
Hoogendijk, JE ;
de Jager, AE ;
Koehler, PJ ;
de Visser, M ;
Verschuuren, JJGM ;
Wintzen, AR .
JOURNAL OF NEUROLOGY, 2005, 252 (12) :1448-1454
[4]  
BEYENBURG S, 1993, CLIN INVESTIGATOR, V71, P351
[5]   Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis [J].
Dalakas, MC .
NEUROLOGY, 1998, 51 (06) :S37-S45
[6]   Inclusion body myositis in Connecticut - Observations in 35 patients during an 8-year period [J].
Felice, KJ ;
North, WA .
MEDICINE, 2001, 80 (05) :320-327
[7]  
FISHER NM, 1990, ARCH PHYS MED REHAB, V71, P729
[8]   Compensatory strategies during normal walking in response to muscle weakness and increased hip joint stiffness [J].
Goldberg, Evan J. ;
Neptune, Richard R. .
GAIT & POSTURE, 2007, 25 (03) :360-367
[9]   Inclusion body myositis: Review of recent literature [J].
Greenberg, Steven A. .
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2009, 9 (01) :83-89
[10]   INCLUSION BODY MYOSITIS - AN UNDERDIAGNOSED CONDITION [J].
HOPKINSON, ND ;
HUNT, C ;
POWELL, RJ ;
LOWE, J .
ANNALS OF THE RHEUMATIC DISEASES, 1993, 52 (02) :147-151